Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

Oncotarget. 2019 Aug 13;10(48):5003-5004. doi: 10.18632/oncotarget.27151.

¹ University of Torino School of Medicine, Candiolo Cancer Institute-FPO, IRCCS, Str. Provinciale, Candiolo, Torino, Italy.
² Department of Surgical and Oncological Sciences, Cellular and Molecular Pathophysiology Laboratory, University of Palermo, Palermo, Italy.
³ Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁴ Molecular Biotechnology Center (MBC), Department of Oncological Sciences, Center for Molecular Systems Biology, Via Nizza, University of Torino, Torino, Italy.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.2962.].